Here, we describe a case with scratch dermatitis encountered as a clinical manifestation of ES.
A 44-year-old Japanese woman was referred to us with a 2-day history of distinct scratch marks due to severe pruritus 18 days after unrelated allogeneic bone marrow transplantation (BMT) from an unrelated donor to treat blast crisis of chronic myeloid leukemia. Human leukocyte antigens between patient and donor were matched at eight of eight loci serologically, and seven of eight loci by DNA typing (mismatch for DRB1). The patient denied having eaten shiitake mushrooms recently. Neither bleomycin nor peplomycin had been administrated. Physical examination showed severe pruritus and erythematous streaks on the trunk on post-BMT day 18 (Fig. 1a) . Maculopapular eruptions appeared on the trunk and extremities on day 19 (Fig. 1b) This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. maculopapular eruptions revealed minimal individual cell keratinization, mild vacuolar degeneration (Fig. 1c) and markedly low counts of CD1a-positive cells in the epidermis (Fig. 1d) . Based on these findings, ES was diagnosed. All symptoms including eruptions improved over a few days without specific treatment and without any change in the pharmacotherapy being administrated.
Major diagnostic criteria of ES are body temperature of 38.0°C or more, erythrodermatous rash involving more than 25% of the body surface area and non-cardiogenic pulmonary edema. 2 Minor criteria are hepatic dysfunction with either total bilirubin of more than 2.0 mg/dL or transaminase levels over double the upper limit of normal, renal insufficiency, weight gain of 2.5% or more and transient encephalopathy. The presence of all three major criteria or two major criteria and one or more minor criteria is diagnostic of ES, and our case fulfilled these criteria. Scratch dermatitis might have been attributable to the severe itch that preceded maculopapular eruptions. The present case was not compatible with urticaria based on the histopathological findings, and the possibility of drug eruption was negated by the improvement in symptoms seen without changes in the pharmacotherapy being administrated. Although a previous report suggested CD4 + cell predominance and decreased numbers of CD1a + cells in the epidermis as suggestive of ES rather than graft-versus-host disease (GVHD), 3 these findings are not definitive points of differentiation between ES and GVHD. This report suggests scratch dermatitis as a potential early sign of ES and means of distinguishing ES from GVHD as early as possible.
